Our evidence demonstrated that dual trigger is capable of preventing severe OHSS while still maintaining excellent high quality embryo rate in in high ovarian responders of GnRH-antagonist protocols. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.